Source: BIOPORTFOLIO

Landsteinerscientific: Iroko Pharmaceuticals Signs New Strategic Agreement With Landsteiner Scientific to Bring ZORVOLEXÂ to Mexico

Iroko Pharmaceuticals LLC a global specialty pharmaceutical company dedicated to advancing the science of analgesia today announced that its affiliate Iroko Pharmaceuticals Inc. signed a licensing agreement with Landsteiner Scientif...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
CEO Avatar

CEO

Miguel Granados

CEO Approval Rating

70/100

Read more